[Pharmacological basis of anti-anginal therapy. II. Effects of nitrites and beta blocking agents (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects*; D003326:Coronary Circulation / Q000187:drug effects; D006801:Humans; D009130:Muscle, Smooth / Q000187:drug effects*; D009573:Nitrites / Q000494:pharmacology*; D010919:Placebos / Q000627:therapeutic use; D011433:Propranolol / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D009573:Nitrites; D010919:Placebos; D014665:Vasodilator Agents; D011433:Propranolol
Bases farmacológicas de la terapéutica de la angina de pecho. II. Efecto de los nitritos y bloqueadores beta adrenérgicos.